NCT04629729 2026-03-19FT819 in Subjects With B-cell MalignanciesFate TherapeuticsPhase 1 Active not recruiting54 enrolled
NCT06152809 2026-03-18CIML NK Cells With Venetoclax for AMLDana-Farber Cancer InstitutePhase 1 Recruiting10 enrolled
NCT06138587 2026-01-02Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell TransplantationDana-Farber Cancer InstitutePhase 1 Recruiting15 enrolled